Literature DB >> 9538969

The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes.

C J Currie1, C L Morgan, J R Peters.   

Abstract

OBJECTIVE: To describe the epidemiology and costs of the acute care of peripheral vascular disease, infection, neuropathy, and ulceration in a U.K. population with special consideration of those patients with diabetes. RESEARCH DESIGN AND METHODS: Routine data describing inpatient care for a 4-year period were analyzed (financial years 1991/1992 to 1994/1995). These data had undergone record-linkage to draw together records from the same patients, and records of patients with diabetes were flagged. Cost estimates were determined by attributing a diagnosis-related group cost-weight to each record.
RESULTS: A total of 4,245 admissions (1.2% of all admissions) had a primary diagnosis of peripheral vascular disease, infection, neuropathy, or ulceration, and 7,379 (2.1%) admissions had these categories recorded in any one of six diagnostic fields. These figures were generated by 3,159 and 4,751 patients, respectively. This represented a range of crude annual incidence of admission of between 1.9 and 2.9 per 1,000 people. Patients with diabetes accounted for 625 (15.4%) of primary admissions, a crude annual incidence of admission of 18.8 per 1,000. The age-standardized relative risk of admission for patients with diabetes to the nondiabetic population was 7.61 for men and 6.85 for women. The length of stay for patients with diabetes was almost twice that of the nondiabetic population (15.5 vs. 8.7 days). The relative risk of hospital mortality (diabetes vs. non-diabetes) was 2.83. Surgical procedures were carried out on 857 patients, 272 (31.2%) with diabetes. This represented an age-standardized relative risk of 31.19. The estimated cost of admissions for primary diagnoses in these categories over 4 years was 6,128,211 pounds ($9,743,855). Patients with diabetes accounted for 1,236,623 pounds ($1,966,230), an excess of 87% attributable to the diabetic state.
CONCLUSIONS: Diabetes is confirmed as a significant risk factor for peripheral vascular disease, infection, neuropathy, and ulceration. The severity of these disorders in terms of increased risk of hospital mortality, length of stay, and risk of surgical procedure is also demonstrated for those patients with diabetes.

Entities:  

Mesh:

Year:  1998        PMID: 9538969     DOI: 10.2337/diacare.21.1.42

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  37 in total

Review 1.  Science, medicine and the future: healing chronic wounds.

Authors:  K G Harding; H L Morris; G K Patel
Journal:  BMJ       Date:  2002-01-19

2.  Reversal of experimental diabetic neuropathy by VEGF gene transfer.

Authors:  P Schratzberger; D H Walter; K Rittig; F H Bahlmann; R Pola; C Curry; M Silver; J G Krainin; D H Weinberg; A H Ropper; J M Isner
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

3.  The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration.

Authors:  Suzan Tabur; Mehmet Ali Eren; Yakup Çelik; Omer Faruk Dağ; Tevfik Sabuncu; Zeynel Abidin Sayiner; Esen Savas
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

4.  The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy.

Authors:  C J Currie; C D Poole; A Woehl; C Ll Morgan; S Cawley; M D Rousculp; M T Covington; J R Peters
Journal:  Diabetologia       Date:  2006-08-30       Impact factor: 10.122

5.  Analysis of racial differences in hospital stays in the presence of geographic confounding.

Authors:  Melanie L Davis; Brian Neelon; Paul J Nietert; Lane F Burgette; Kelly J Hunt; Andrew B Lawson; Leonard E Egede
Journal:  Spat Spatiotemporal Epidemiol       Date:  2019-07-05

6.  Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.

Authors:  S Gadau; C Emanueli; S Van Linthout; G Graiani; M Todaro; M Meloni; I Campesi; G Invernici; F Spillmann; K Ward; P Madeddu
Journal:  Diabetologia       Date:  2006-01-17       Impact factor: 10.122

7.  Ager Deletion Enhances Ischemic Muscle Inflammation, Angiogenesis, and Blood Flow Recovery in Diabetic Mice.

Authors:  Raquel López-Díez; Xiaoping Shen; Gurdip Daffu; Md Khursheed; Jiyuan Hu; Fei Song; Rosa Rosario; Yunlu Xu; Qing Li; Xiangmei Xi; Yu Shan Zou; Huilin Li; Ann Marie Schmidt; Shi Fang Yan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-22       Impact factor: 8.311

8.  Estimating the costs associated with the management of patients with chronic wounds using linked routine data.

Authors:  Ceri J Phillips; Ioan Humphreys; Jacqui Fletcher; Keith Harding; George Chamberlain; Steven Macey
Journal:  Int Wound J       Date:  2015-03-26       Impact factor: 3.315

9.  The silent overall burden of foot disease in a representative hospitalised population.

Authors:  Peter A Lazzarini; Sheree E Hurn; Suzanne S Kuys; Maarten C Kamp; Vanessa Ng; Courtney Thomas; Scott Jen; Jude Wills; Ewan M Kinnear; Michael C d'Emden; Lloyd F Reed
Journal:  Int Wound J       Date:  2016-10-03       Impact factor: 3.315

10.  A questionnaire for determining prevalence of diabetes related foot disease (Q-DFD): construction and validation.

Authors:  Caroline A Brand; Peter G Colman; Donald A Campbell; Shan M Bergin
Journal:  J Foot Ankle Res       Date:  2009-11-25       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.